Abaxis, Inc. (ABAX)
-NasdaqGS 45.89 
1.00(2.13%) 4:00PM EDT|After Hours
:
45.89 0.00 (0.00%) 4:32PM EDT
| Prev Close: | 46.89 |
|---|
| Open: | 46.95 |
|---|
| Bid: | N/A |
|---|
| Ask: | 49.00 x 100 |
|---|
| 1y Target Est: | 45.71 |
|---|
| Beta: | 1.12 |
|---|
| Next Earnings Date: | 22-Jul-13 |
|---|
| Day's Range: | 45.59 - 46.96 |
|---|
| 52wk Range: | 33.28 - 49.45 |
|---|
| Volume: | 96,151 |
|---|
| Avg Vol (3m): | 138,561 |
|---|
| Market Cap: | 1.01B |
|---|
| P/E (ttm): | 37.31 |
|---|
| EPS (ttm): | 1.23 |
|---|
| Div & Yield: | N/A (N/A) |
|---|
The broker you select will become the default broker for Trade Now
Quotes delayed, except where indicated otherwise. Currency in USD.
Headlines
- Is Life Technologies Overvalued?at Motley Fool(Wed 10:50AM EDT)
- ABAXIS INC Files SEC form 10-K, Annual ReportEDGAR Online(Fri, Jun 14)
- Heska Provides Investors Low Risk / High Reward Opportunity In Companion Animal Spaceat Seeking Alpha(Tue, Jun 11)
- Abaxis, Inc. to Present at the Jefferies 2013 Global Healthcare ConferencePR Newswire(Wed, May 29)
- Abaxis, Inc. to Present at the Stifel Annual Dental & Veterinary ConferencePR Newswire(Tue, May 21)
- Abaxis, Inc. to Present at the Bank of America Merrill Lynch 2013 Health Care ConferencePR Newswire(Wed, May 8)
- ABAXIS INC Files SEC form 8-K, Change in Directors or Principal OfficersEDGAR Online(Tue, Apr 30)
- 3 Healthcare Stock Winners and 2 Losers After Earnings Are Digestedat Wall St. Cheat Sheet(Sun, Apr 28)
- Earnings Beat for ABAX, Sluggish OverallZacks(Fri, Apr 26)
- Oversold Conditions For Abaxis (ABAX)at TheStreet(Fri, Apr 26)
- ABAXIS CEO Discusses Q4 2013 Results - Earnings Call Transcriptat Seeking Alpha(Thu, Apr 25)
- Abaxis Earnings: Here’s Why Investors are Ambivalent Nowat Wall St. Cheat Sheet(Thu, Apr 25)
- Abaxis Reports Financial Performance For The Fourth Quarter And Fiscal 2013PR Newswire(Thu, Apr 25)
- ABAXIS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and ExhibitsEDGAR Online(Thu, Apr 25)
- Q4 2013 ABAXIS INC Earnings Release - After Market CloseCCBN(Thu, Apr 25)
Key Statistics
| Forward P/E (1 yr): | 35.03 |
|---|
| P/S (ttm): | 5.57 |
|---|
| Ex-Dividend Date: | 13-Dec-12 |
|---|
Analysts
| Annual EPS Est
(Mar-14)
: | 1.06 |
|---|
| Quarterly EPS Est
(Jun-13)
: | 0.23 |
|---|
| Mean Recommendation*: | 2.6 |
|---|
| PEG Ratio (5 yr expected): | 2.92 |
|---|
Business Summary
Abaxis, Inc. develops, manufactures, markets, and sells portable blood analysis systems for use in human or veterinary patient-care setting to provide blood constituent measurements for clinicians worldwide.
View More